224 related articles for article (PubMed ID: 31276205)
1. Melatonin: An important anticancer agent in colorectal cancer.
Mirza-Aghazadeh-Attari M; Mohammadzadeh A; Mostavafi S; Mihanfar A; Ghazizadeh S; Sadighparvar S; Gholamzadeh S; Majidinia M; Yousefi B
J Cell Physiol; 2020 Feb; 235(2):804-817. PubMed ID: 31276205
[TBL] [Abstract][Full Text] [Related]
2. The Role of Melatonin in Colorectal Cancer.
Iravani S; Eslami P; Dooghaie Moghadam A; Moazzami B; Mehrvar A; Hashemi MR; Mansour-Ghanaei F; Mansour-Ghanaei A; Majidzadeh-A K
J Gastrointest Cancer; 2020 Sep; 51(3):748-753. PubMed ID: 31792737
[TBL] [Abstract][Full Text] [Related]
3. The potential therapeutic actions of melatonin in colorectal cancer.
Chok KC; Ng CH; Koh RY; Ng KY; Chye SM
Horm Mol Biol Clin Investig; 2019 May; 39(1):. PubMed ID: 31141480
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Opportunities in Colorectal Cancer: Focus on Melatonin Antioncogenic Action.
Wu H; Liu J; Yin Y; Zhang D; Xia P; Zhu G
Biomed Res Int; 2019; 2019():9740568. PubMed ID: 31637261
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma.
Lu KH; Lin RC; Yang JS; Yang WE; Reiter RJ; Yang SF
Cells; 2019 Dec; 8(12):. PubMed ID: 31842295
[TBL] [Abstract][Full Text] [Related]
6. Melatonin as a potential inhibitor of colorectal cancer: Molecular mechanisms.
Shafabakhsh R; Reiter RJ; Davoodabadi A; Asemi Z
J Cell Biochem; 2019 Aug; 120(8):12216-12223. PubMed ID: 31087705
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota.
Pan S; Guo Y; Hong F; Xu P; Zhai Y
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166281. PubMed ID: 34610472
[TBL] [Abstract][Full Text] [Related]
8. Melatonin: A Potential Antineoplastic Agent in Breast Cancer.
Samanta S
J Environ Pathol Toxicol Oncol; 2022; 41(4):55-84. PubMed ID: 36374962
[TBL] [Abstract][Full Text] [Related]
9. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
[TBL] [Abstract][Full Text] [Related]
10. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects.
Zare H; Shafabakhsh R; Reiter RJ; Asemi Z
J Ovarian Res; 2019 Mar; 12(1):26. PubMed ID: 30914056
[TBL] [Abstract][Full Text] [Related]
11. Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved.
Bastani S; Akbarzadeh M; Rastgar Rezaei Y; Farzane A; Nouri M; Mollapour Sisakht M; Fattahi A; Akbarzadeh M; Reiter RJ
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639215
[TBL] [Abstract][Full Text] [Related]
12. Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo.
Wang Q; Sun Z; Du L; Xu C; Wang Y; Yang B; He N; Wang J; Ji K; Liu Y; Liu Q
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544713
[TBL] [Abstract][Full Text] [Related]
13. Potential use of melatonin in skin cancer treatment: A review of current biological evidence.
Pourhanifeh MH; Mahdavinia M; Reiter RJ; Asemi Z
J Cell Physiol; 2019 Aug; 234(8):12142-12148. PubMed ID: 30618091
[TBL] [Abstract][Full Text] [Related]
14. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways.
Pourhanifeh MH; Mehrzadi S; Kamali M; Hosseinzadeh A
Eur J Pharmacol; 2020 Nov; 886():173471. PubMed ID: 32877658
[TBL] [Abstract][Full Text] [Related]
15. Does the use of melatonin overcome drug resistance in cancer chemotherapy?
Asghari MH; Ghobadi E; Moloudizargari M; Fallah M; Abdollahi M
Life Sci; 2018 Mar; 196():143-155. PubMed ID: 29374563
[TBL] [Abstract][Full Text] [Related]
16. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
[TBL] [Abstract][Full Text] [Related]
17. Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review.
Mortezaee K; Najafi M; Farhood B; Ahmadi A; Potes Y; Shabeeb D; Musa AE
Life Sci; 2019 Jul; 228():228-241. PubMed ID: 31077716
[TBL] [Abstract][Full Text] [Related]
18. The potential utility of melatonin in the treatment of childhood cancer.
Chao YH; Wu KH; Yeh CM; Su SC; Reiter RJ; Yang SF
J Cell Physiol; 2019 Nov; 234(11):19158-19166. PubMed ID: 30945299
[TBL] [Abstract][Full Text] [Related]
19. Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
Lo Sardo F; Muti P; Blandino G; Strano S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28878191
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological mechanisms of death resistance in colorectal carcinoma.
Huang CY; Yu LC
World J Gastroenterol; 2015 Nov; 21(41):11777-92. PubMed ID: 26557002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
